Search


	Podcast:		In conversation with...
	Episode:		Lilian Tina Minja and Norbert Heinrich on TB drug development
	Category:		Science & Medicine
	Duration:		00:29:53
	Publish Date:		2025-07-09 08:00:00
	Description:		Lilian Tina Minja and Norbert Heinrich discuss a pair of trials they recently published in The Lancet Infectious Diseases, ‘A prospective, randomised, open label phase 2b dose-finding trial of sutezolid in combination with bedaquiline, delamanid and moxifloxacin for pulmonary tuberculosis: SUDOCU’ and ‘A prospective, randomised, open label phase 2b dose-finding trial of delpazolid in combination with bedaquiline, delamanid and moxifloxacin for pulmonary tuberculosis: DECODE’ and the wider implications of the findings of these trials for TB drug development and TB treatment. Read the trials: https://www.thelancet.com/journals/laninf/article/PIIS1473-3099(25)00213-0/fulltext?dgcid=buzzsprout_icw_podcast_July_25_laninf https://www.thelancet.com/journals/laninf/article/PIIS1473-3099(25)00289-0/fulltext?dgcid=buzzsprout_icw_podcast_July_25_laninf Continue this conversation on social! Follow us today at... https://thelancet.bsky.social/ https://instagram.com/thelancetgroup https://facebook.com/thelancetmedicaljournal https://linkedIn.com/company/the-lancet https://youtube.com/thelancettv
	Total Play:		0